Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:MORF

Morphic (MORF) Stock Price, News & Analysis

Morphic logo

About Morphic Stock (NASDAQ:MORF)

Advanced Chart

Key Stats

Today's Range
$56.99
$56.99
50-Day Range
$55.74
$56.99
52-Week Range
$19.34
$57.00
Volume
400 shs
Average Volume
1.27 million shs
Market Capitalization
$2.85 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MORF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Morphic and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MORF Stock News Headlines

Morphic Ethical Equities Fund Limited
Eli Lilly acquires Morphic in IBD portfolio expansion
Is This Stock the 'Next Nvidia'?
'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, and has now reached every AI company in America... including Nvidia, Microsoft, and Meta.tc pixel
MORF Jan 2025 25.000 put (MORF250117P00025000)
Morphic Holding (MORF) Earnings Dates & Reports
See More Headlines

MORF Stock Analysis - Frequently Asked Questions

Morphic Holding, Inc. (NASDAQ:MORF) posted its quarterly earnings results on Thursday, July, 25th. The company reported ($1.15) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.96) by $0.19.

Morphic (MORF) raised $75 million in an initial public offering on Thursday, June 27th 2019. The company issued 5,000,000 shares at $14.00-$16.00 per share. Jefferies, Cowen, BMO Capital Markets and Wells Fargo Securities acted as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Morphic investors own include Invesco QQQ (QQQ), NVIDIA (NVDA), SPDR S&P 500 ETF Trust (SPY), Advanced Micro Devices (AMD), SPDR Dow Jones Industrial Average ETF Trust (DIA), Meta Platforms (META) and Tesla (TSLA).

Company Calendar

Last Earnings
7/25/2024
Today
8/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:MORF
CIK
1679363
Fax
N/A
Employees
100
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($3.50)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$152.10 million
Net Margins
N/A
Pretax Margin
-29,119.96%
Return on Equity
-26.62%
Return on Assets
-25.74%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
24.13
Quick Ratio
24.13

Sales & Book Value

Annual Sales
$520 thousand
Price / Sales
5,490.11
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$12.31 per share
Price / Book
4.63

Miscellaneous

Outstanding Shares
50,094,000
Free Float
37,270,000
Market Cap
$2.85 billion
Optionable
Optionable
Beta
1.49

Social Links

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:MORF) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners